COMPOSITION IN MICRO-ENCAPSULATED FORM, BASED ON N- BUTYRIC ACID OR THE DERIVATIVES THEREOF, FOR TREATING CROHN'S DISEASE OR ULCERATIVE RECTAL COLITIS

摘要

A composition in micro-encapsulated form, comprising a core based on n- butyric acid or a derivative thereof, and a coating based on a lipid matrix which surrounds the core, in which the matrix has a content of C14-C22 long chain saturated fatty acids between 40% and 95%, is used for the treatment of ulcerative rectal colitis or Crohn's disease.